Ross A. D. Bathgate

14.4k total citations · 2 hit papers
282 papers, 10.6k citations indexed

About

Ross A. D. Bathgate is a scholar working on Public Health, Environmental and Occupational Health, Occupational Therapy and Social Psychology. According to data from OpenAlex, Ross A. D. Bathgate has authored 282 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Public Health, Environmental and Occupational Health, 28 papers in Occupational Therapy and 28 papers in Social Psychology. Recurrent topics in Ross A. D. Bathgate's work include Pregnancy-related medical research (231 papers), Neuroendocrine regulation and behavior (28 papers) and Occupational Health and Performance (28 papers). Ross A. D. Bathgate is often cited by papers focused on Pregnancy-related medical research (231 papers), Neuroendocrine regulation and behavior (28 papers) and Occupational Health and Performance (28 papers). Ross A. D. Bathgate collaborates with scholars based in Australia, United States and Germany. Ross A. D. Bathgate's co-authors include Roger J. Summers, Geoffrey W. Tregear, John D. Wade, Chrishan S. Samuel, Richard Ivell, Mohammed Akhter Hossain, Sharon Layfield, Michelle L. Halls, Andrew L. Gundlach and Daniel J. Scott and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Ross A. D. Bathgate

279 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relaxin Family Peptides and Their Receptors

2013 405 citations Ross A. D. Bathgate, Michelle L. Halls et al. profile →
Relaxin Reverses Cardiac and Renal Fibrosis in Spontaneously Hypertensive Rats

2005 164 citations Ross A. D. Bathgate, Chrishan S. Samuel et al. profile →

Peers

Countries citing papers authored by Ross A. D. Bathgate

Since Specialization

Citations

This map shows the geographic impact of Ross A. D. Bathgate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross A. D. Bathgate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross A. D. Bathgate more than expected).

Fields of papers citing papers by Ross A. D. Bathgate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross A. D. Bathgate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross A. D. Bathgate. The network helps show where Ross A. D. Bathgate may publish in the future.

Co-authorship network of co-authors of Ross A. D. Bathgate

This figure shows the co-authorship network connecting the top 25 collaborators of Ross A. D. Bathgate. A scholar is included among the top collaborators of Ross A. D. Bathgate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross A. D. Bathgate. Ross A. D. Bathgate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology 2024 ·Biochemical Pharmacology ·Irina U. Agoulnik, (unknown), Courtney Myhr, Ross A. D. Bathgate, Martina Kočan, Yingjie Peng, Ronald M. Lindsay, (unknown), Alexander I. Agoulnik	0
2	Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays 2024 ·Biochemical Pharmacology ·(unknown), (unknown), (unknown), Mohammed Akhter Hossain, Ross A. D. Bathgate	3
3	Modulation of contextual fear acquisition and extinction by acute and chronic relaxin-3 receptor (RXFP3) activation in the rat retrosplenial cortex 2024 ·Biochemical Pharmacology ·(unknown), Isis Gil‐Miravet, (unknown), Ross A. D. Bathgate, Mohammed Akhter Hossain, Esther Castillo-Gómez, Andrew L. Gundlach, Francisco E. Olucha‐Bordonau	0
4	Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1 2023 ·ACS Pharmacology & Translational Science ·Mohammed Akhter Hossain, (unknown), (unknown), (unknown), Ian Harrison, (unknown), Stavros Selemidis, Chrishan S. Samuel, Ross A. D. Bathgate	2
5	Unravelling the mechanism of neurotensin recognition by neurotensin receptor 1 2023 ·Nature Communications ·(unknown), (unknown), (unknown), Ching‐Seng Ang, Shuai Nie, Nicholas A. Williamson, Michael D. W. Griffin, Ross A. D. Bathgate, Daniel J. Scott, Thomas R. Weikl, Guy N. L. Jameson, Paul R. Gooley	3
6	A Real-Time, Plate-Based BRET Assay for Detection of cGMP in Primary Cells 2022 ·International Journal of Molecular Sciences ·(unknown), Martina Kočan, (unknown), Sarah A. Marshall, Daniel J. Scott, Ross A. D. Bathgate	5
7	High-Throughput Screening Campaign Identified a Potential Small Molecule RXFP3/4 Agonist 2021 ·Molecules ·Guangyao Lin, Yang Feng, Xiaoqing Cai, Caihong Zhou, Lijun Shao, Yan Chen, Linhai Chen, Qing Liu, (unknown), Ross A. D. Bathgate, Dehua Yang, Ming‐Wei Wang	5
8	Relaxin family peptide receptors in GtoPdb v.2021.3 2021 ·IUPHAR/BPS Guide to Pharmacology CITE ·Ross A. D. Bathgate, Thomas Dschietzig, Andrew L. Gundlach, Michelle L. Halls, Roger J. Summers	1
9	A Novel Antagonist Peptide Reveals a Physiological Role of Insulin-Like Peptide 5 in Control of Colorectal Function 2021 ·ACS Pharmacology & Translational Science ·Ruslan V. Pustovit, Xiaozhou Zhang, (unknown), (unknown), Mengjie Liu, Ada Koo, (unknown), (unknown), Martina Kočan, Shuai Nie, Ross A. D. Bathgate, John B. Furness, Mohammed Akhter Hossain	16
10	Probing the correlation between ligand efficacy and conformational diversity at the α1A-adrenoreceptor reveals allosteric coupling of its microswitches 2020 ·Journal of Biological Chemistry ·(unknown), Lisa M. Williams, (unknown), (unknown), (unknown), Martina Kočan, (unknown), Michael D. W. Griffin, Ross A. D. Bathgate, Daniel J. Scott, Paul R. Gooley	22
11	Exploring the Use of Helicogenic Amino Acids for Optimising Single Chain Relaxin-3 Peptide Agonists 2020 ·Biomedicines ·(unknown), Shu Hui Wang, (unknown), Mohammed Akhter Hossain, Richard J. Clark, Ross A. D. Bathgate, K. Johan Rosengren	3
12	Using the novel HiBiT tag to label cell surface relaxin receptors for BRET proximity analysis 2019 ·Pharmacology Research & Perspectives ·(unknown), Martina Kočan, (unknown), Daniel J. Scott, Ross A. D. Bathgate	10
13	Real‐time examination of cAMP activity at relaxin family peptide receptors using a BRET‐based biosensor 2018 ·Pharmacology Research & Perspectives ·(unknown), (unknown), (unknown), Mohammed Akhter Hossain, Asuka Inoue, Martina Kočan, Ross A. D. Bathgate	11
14	A Novel Ultra-Stable, Monomeric Green Fluorescent Protein For Direct Volumetric Imaging of Whole Organs Using CLARITY 2018 ·Scientific Reports ·Daniel J. Scott, (unknown), (unknown), Verena C. Wimmer, Nicholas A. Veldhuis, (unknown), Mouna Haidar, Steven Petrou, Ross A. D. Bathgate, Michael D. W. Griffin	69
15	The relaxin receptor as a therapeutic target - perspectives from evolution Cheek for updates and drug targeting 2018 ·Pharmacology & Therapeutics ·Ross A. D. Bathgate, Martina Kočan, Daniel J. Scott, Mohammed Akhter Hossain, Sara V. Good, Sergey Yegorov, Jan Bogerd, Paul R. Gooley	1
16	Characterisation of a cell-free synthesised G-protein coupled receptor 2017 ·Scientific Reports ·Patrick J. Shilling, Fabian Bumbak, Daniel J. Scott, Ross A. D. Bathgate, Paul R. Gooley	14
17	A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1 2016 ·Chemical Science ·Mohammed Akhter Hossain, Martina Kočan, Song T. Yao, Simon G. Royce, (unknown), (unknown), Nitin A. Patil, Ian Harrison, K. Johan Rosengren, Stavros Selemidis, Roger J. Summers, John D. Wade, Ross A. D. Bathgate, Chrishan S. Samuel	71
18	Functional link between bone morphogenetic proteins and insulin-like peptide 3 signaling in modulating ovarian androgen production 2013 ·Proceedings of the National Academy of Sciences ·Claire Glister, Leanne Satchell, Ross A. D. Bathgate, John D. Wade, (unknown), Richard Ivell, Ravinder Anand‐Ivell, Raymond J. Rodgers, P. G. Knight	58
19	Preparation of canine relaxin by Fmoc-solid phase synthesis and regioselective disulfide bond formation within the A- and B-chains 2013 ·Monash University Research Portal (Monash University) ·Feng Lin, Julien Tailhades, Linda J. Chan, Ross A. D. Bathgate, Mohammed Akhter Hossain, John D. Wade	5
20	INSL3/RXFP2 Signaling in Testicular Descent 2009 ·Annals of the New York Academy of Sciences ·Shu Feng, Alberto Ferlin, Anne Truong, Ross A. D. Bathgate, John D. Wade, Sean T. Corbett, (unknown), Mounia Tannour‐Louet, Dolores J. Lamb, Carlo Foresta, Alexander I. Agoulnik	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact